期刊
JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 369, 期 -, 页码 294-302出版社
ELSEVIER
DOI: 10.1016/j.jns.2016.08.057
关键词
Myasthenia gravis; Immunosuppression; Corticosteroid; Intravenous immunoglobulin; Thymectomy
Therapies for myasthenia gravis (MG) include symptomatic and immunosuppressive treatment. Options for immunosuppression include corticosteroids, azathioprine, mycophenolate mofetil, cyclosporine, tacrolimus, methotrexate, rituximab, cyclophosphamide, intravenous immunoglobulin, plasmapheresis, and thymectomy. The practical aspects of long-term immunosuppressive therapy in MG will be critically reviewed in this article. Treatment for ocular and generalized myasthenia gravis will be discussed. Application of these therapies needs to be considered in conjunction with their efficacy, disease subtypes and severity, and patient co-morbidities. (C) 2016 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据